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Background/aim: Ovarian hyperstimulation syndrome (OHSS) is a complication of ovarian stimulation with increased vascular
endothelial growth factor (VEGF) and vascular permeability in the ovarian tissue. Transient receptor potential melastatin 2 (TRPM2)
is known to be associated with angiogenesis and vascular permeability. In this experimental study, we aimed to investigate the activity
of TRPM2 in the development of OHSS.
Materials and methods: Fourteen immature female rats were divided into two groups. Group 1 was the control group, and Group
2 was the OHSS group that was exposed to 10 IU of subcutaneous application of FSH for four days and 30 IU of human chorionic
gonadotropin (hCG) on the 5th day. At the end of the experiment, the ovaries were removed. The right ovarian tissues were stored in
10% formol for histopathological and immunohistochemical examination. The left ovarian tissues were stored at –80 °C for biochemical
examinations. VEGF, tumor necrosis factor-alpha (TNF‐α) and malondialdehyde (MDA) levels were measured in the ovarian tissue.
Congestion, edema, apoptosis and TRPM2 immunoreactivity were evaluated.
Results: There was a significant increase in ovarian weight in the OHSS group compared to the control group. There was a significant
increase in congestion, edema, apoptosis and TRPM2 immunoreactivity in the OHSS group. A significant increase in tissue levels of
VEGF, TNF‐α and MDA was also found in the OHSS group compared to the control group.
Conclusion: As a result of our experiment, it was found that increased TRPM2 immunoreactivity on hyperstimulated rat ovary may be
the reason or result of edema and congestion. Further studies are needed to discuss our results.
Key words: Rat, OHSS, TRPM2, VEGF, angiogenesis

1. Introduction
Ovarian hyperstimulation syndrome (OHSS) is the most
serious complication associated with assisted reproductive
treatments. Its pathophysiology includes increased
capillary permeability which leads to a variety of signs
and symptoms, such as hypotension, ascites and pleural
effusion [1]. While mild OHSS is seen in 32% of in vitro
fertilization (IVF) cycles, 10%–15% of patients develop
moderate and 5%–8% severe OHSS [2,3]. Generally, it
is believed that human chorionic gonadotropin (hCG)
hormone is the most important factor for the development
of this life-threatening condition [4]. The increased
secretion of some mediators such as interleukins (ILs),
vascular endothelial growth factor (VEGF), which
occupies a special place for interleukins, angiotensin II (Ag
II), insulin-like growth factor‐1 (IGF‐1), epidermal growth

factor (EGF), transforming growth factor (TGF) a and b,
basic fibroblast growth factor (bFGF), platelet-derived
growth (PDGF) by granulosa and lutein cells lead to
increased capillary permeability and accumulation of fluid
in the third space [5]. Recent studies have shown that these
molecules are responsible for the inflammatory processes
associated with follicular maturation, ovulation, corpus
luteum function and embryo implantation [5]. It has been
reported that other mediators such as histamine, prolactin,
prostaglandins and renin‐angiotensin also play a role in
the pathophysiology of OHSS. As OHSS progresses, it leads
to ascites formation and⁄or pleural effusion, loss of fluid
from the vascular compartment (hemoconcentration),
decreased kidney perfusion, followed by oliguria, kidney
failure, and thrombosis [6].
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Transient receptor potential melastatin 2 (TRPM2)
channels are voltage independent cation channels
which have been detected in tissues such as brain, bone
marrow, lung, heart, pancreatic beta cells, leukocytes
and vascular endothelium, and they are permeable to
calcium, an important second messenger [7,8]. There
are three extracellular factors which are effective on the
opening of active TRPM2 cation channels: oxidative
stress, ADPR/nicotinamide adenine dinucleotide (NAD+)
metabolism and tumor necrosis factor-alpha (TNF‐α)
[9]. Malondialdehyde (MDA), produced as a result of
lipid peroxidation of cell membranes, is a metabolite that
reflects the imbalance between oxidative and antioxidative
homeostasis [10]. In our study, we aimed to investigate
the tissue TNF‐α and MDA levels together with TRPM2
activity due to their relationship with oxidative stress.
Endothelial Ca2+ signals play a very important
role in angiogenesis and arteriogenesis [11]. Multiple
proangiogenic factors, such as VEGF, bFGF, PDGF,
epidermal growth factor (EGF), stromal-derived factor1α (SDF-1α) and angiopoietin, regulate endothelial cell
behavior by causing an increase in intracellular Ca2+
concentration [12,13]. TRP channels regulate endothelial
cell function by mediating extracellular Ca2+ input in
response to chemical, mechanical, and thermal stimuli
[14].
Endothelial TRP channels represent potential
therapeutic targets in many disorders characterized
by abnormal vascularization such as cancer, ischemic
disorders, retinal degeneration, and neurodegeneration
[15]. Due to the proven TRPM2 expression in granulosa
cells of in situ human follicles [16] and its close association
with angiogenesis, we aimed to investigate TRPM2 ion
channel activity in OHSS pathophysiology in an OHSS rat
model.
2. Materials and methods
2.1. Animal model
This experimental study was performed in the Fırat
University Experimental Research Center (FÜDAM)
between April 2019 and July 2019, after approval by
the Local Ethics Committee of Fırat University Animal
Experiments (Date: 16. 01. 2019, Meeting Number:
2019⁄01, Decision No: 14). All rats for the study were
purchased from FÜDAM. All research animals were
treated in compliance with the guidelines for the care and
use of animals approved by the institution in accordance
to principles of laboratory animal care (NIH Guide
for the Care and Use of Laboratory Animals, Institute
of Laboratory Animal Researches, National Research
Council, Washington, DC, USA). The rats were caged in
a controlled environment of 22 °C with 12 h light ⁄ dark
cycles (lights‐on 8 AM to 8 PM). Standard rat feed and
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reverse-osmosis-purified water were provided ad libitum.
All the researchers participating in the experimental study
had a certificate of animal use in experimental research.
2.2. Experimental protocol
We used immature rats (22 days old) in our experiment
because ovarian physiology could be simplified and
immature rats were not affected by the corpus luteum of
previous cycles [17]. Twenty-two‐day‐old female Wistar
albino rats (each weighing between 50 and 60 g) were
randomly divided into two groups.
Group 1 (G1) (control group; n = 7): the rats received
0.1 mL subcutaneous saline from days 22–26. These rats
were decapitated on 27th day.
Group 2 (G2) (OHSS group; n = 7): the rats were given
with 10 IU of pregnant mare serum gonadotropin [PMSG;
Folligon, Intervet India Pvt. Ltd (MAH-India), Pune,
India] subcutaneous for 4 consecutive days from the 22nd
to the 25th day of life followed by a subcutaneous injection
of 30 IU of hCG [PREGNYL 1500 IU Lyophilized ampoule
(Merck Sharp Dohme İlaçları Ltd. Şti., İstanbul, Turkey)
contains 1500 IU (international units) of hCG in each
ampoule] on the 26th day to induce OHSS. The rats were
decapitated on the day after OHSS induction (27th day).
The rats were monitored daily, and no evidence
of toxicity was reported based on body weight, food
consumption, grooming behavior or activity levels
compared to controls.
The rats were anesthetized with an intramuscular
injection of ketamine (50 mg/kg; Ketalar; Parke Davis,
Turkey) and xylazine (10 mg/kg; Rompun; Bayer AG,
Berlin, Germany) under aseptic conditions. The abdomen
was opened with a midline incision. On the 27th day, in
G1 and G2, rats’ abdomens were exposed under anesthesia
to see whether there was any ascites, and the ovaries were
removed and weighed. Then, left ovarian tissues were
wrapped in aluminum foil and stored at –80 oC. The right
ovarian tissues were kept in 10% formol. At the end of
experiment, all rats were sacrificed. The all samples were
stored until the laboratory examinations were carried out
under appropriate conditions.
2.3. Biochemical evaluation
All of the biochemical evaluations were done in Fırat
University Medical Faculty, Medical Biochemistry
Laboratory.
2.3.1. Preparation of tissue samples
Fresh ovarian tissues were washed with 0.9% cold ( +4 ºC)
sodium chloride (NaCl solution, 9 g/L) and dried with
blotter paper. The tissues were then homogenized with
a homogenizer (Ultra Turrax Type T25‐B, IKA-Werke
GmbH, Staufen, Germany) in 0.01M phosphate buffered
saline (PBS) solution [(10 mM Na2HP04, 10 mM KH2PO4,
0.9 g NaCl /100 ml and pH 7.4), Phosphate Buffered
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Saline, P4417, Sigma-Aldrich, St. Louis, MO, USA] for 3
min at 16000 rpm. Homogenization was carried out in an
ice bucket. The homogenate was centrifuged at 5000 × g
for 1 h (at + 4 ºC) and its supernatants were separated. The
resulting supernatants were portioned to avoid repeated
freeze-thaw cycles and stored at –80 °C to be thawed on the
day of assay VEGF, TNF‐α, and malondialdehyde (MDA)
levels were determined in the supernatant by enzymelinked immunosorbent assay (ELISA) method. The results
were normalized to the protein content in a sample and the
estimation of protein content was performed by the Lowry
method [18].
2.3.2. Measurement of tissue VEGF Levels
VEGF levels in ovarian supernatant were determined by
rat ELISA kit (SunRed Biotechnology Company, Shanghai,
China, Catalog #: 201111636) according to manufacturer’s
recommendations. The optical density of each well was
measured at 450 nm using an ELX 800 ELISA reader. The
concentrations were calculated based on standard curves.
In plate washing, Bio‐tek ELX50 (BioTek Instruments,
Winooski, VT, USA) was used as an automatic washer.
Results were expressed in ng/mL. Tissue VEGF results
were calculated by multiplying the dilution factor by
considering dilution rate and expressed in ng/mg protein.
The measurement range was 0.15–40 ng/mL and the
minimum measurable level was 0.133 ng/mL.
2.3.3. Measurement of tissue TNF‐α Levels
TNF‐α levels were measured in the tissue samples
according to the kit procedure, using the rat ELISA
kit (SunRed Biotechnology Company, Shanghai,
China, Catalog #: 201110765). Absorbances were
read spectrophotometrically at 450 nm in the ELX800
ELISA reader. In plate washing, Bio‐tek ELX50 (BioTek
Instruments) was used as an automatic washer. Results
are expressed in ng/L. TNF‐α results were calculated by
multiplying by dilution factor considering the dilution
rate. The tissue TNF‐α levels were expressed as ng/g
protein. The measuring range was 8–1000 ng/L and the
minimum measurable level was 5.127 ng/L.
2.3.4. Measurement of tissue MDA Levels
MDA levels were measured using rat MDA ELISA kit
(SunRed Biotechnology Company, Catalog #: 201110157)
according to the manufacturer’s protocol. The absorbance
value (OD) of each pore was measured at 450 nm in the
ELX800 ELISA reader. The results were normalized to the
protein content in a sample and expressed in nmol/mg
protein.
2.4. Histological evaluations
The all histological and immunohistochemical evaluations
were done in Fırat University Medical Faculty Histology
and Embryology Laboratory. The ovarian tissues obtained
in each group were embedded in paraffin blocks after

fixing with 10% formol. Sections of 4–6 µm thickness were
obtained from those paraffin blocks. The sections were
stained with hematoxylin and eosin (H&E), and examined
and captured under the light microscope. The congestion
and edema in ovarian tissue was scored on a scale ranging
from 0 to 3 (0 = none; 1 = mild; 2 = moderate; 3 = severe)
[19].
2.5. Terminal deoxynucleotidyl transferase dUTP nick
end labelling (TUNEL) staining
Sections of 5–6 μm thickness obtained from paraffin
blocks were mounted on polylysine glass slides. Apoptotic
cells were detected using the ApopTag Plus Peroxidase In
Situ Apoptosis Detection Kit (Chemicon International,
Temecula, CA, USA, Cat no: S7101) according to the
manufacturer’s instructions. Tissues deparaffinized with
xylene were passed through graded alcohol series and
washed with PBS. Tissues incubated for 10 min with 0.05%
proteinase K were incubated for 5 min with 3% hydrogen
peroxide to prevent endogenous peroxidase activity.
After washing the tissues with PBS, they were incubated
with equilibration buffer for 6 minutes and incubated
for 60 min with a working solution (70% μL reaction
buffer + 30% TdT enzyme) at 37 ºC. Apoptotic cells were
visualized with the diaminobenzidine (DAB) substrate.
The cross-staining sections with Harris hematoxylin
were sealed with the appropriate capping solution. The
prepared preparations were examined, photographed, and
examined under computer‐assisted Leica DM500 light
microscope (Leica Microsystems, Wetzlar, Germany). In
the evaluation of TUNEL staining, blue‐stained nuclei by
Harris hematoxylin were evaluated as normal, whereas
cells displaying brown-stained nuclei were considered
as apoptotic. At least 500 cells were counted in normal
and apoptotic areas in randomly selected areas at × 10
magnification in sections. Apoptotic index (AI) was
calculated as a percentage (%) by proportioning apoptotic
cells to total (normal + apoptotic) cells [20].
2.6 Immunohistochemical staining experiments
Sections of 4–6 µm thickness were obtained from paraffin
blocks and taken on polysynic slides. The deparaffinized
tissues were passed through graded alcohol series and
boiled in a citrate buffer solution for antigen retrieval at a
pH of 6 in a microwave oven (750W) for 12 min. Tissues
were kept at room temperature for about 20 min after
boiling to cool. The cooled tissues were washed with PBS
for 3 × 5 min, then incubated with hydrogen peroxide
block solution (Hydrogen Peroxide Block, TA‐125‐HP,
Lab Vision Corporation, Fremont, CA, USA) for 5 min
to prevent endogenous peroxidase activity. Tissues were
washed for 3 × 5 min with PBS applied Ultra V Block
(TA‐125‐UB, Lab Vision Corporation) solution to prevent
ground staining. After this procedure, the tissues were
incubated with TRPM2 primary antibodies (Rabbit Anti‐
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TRPM2 antibody, ab101738, Abcam, Cambridge, UK)
diluted at the rate of 1/200, at room temperature for 60
min. The tissues were washed with PBS for 3 × 5 min after
primary antibody administration, and then incubated
at room temperature in the humid environment for 30
min with the secondary antibody (biotinylated goat
antipolyvalent (antimouse/rabbit IgG), TP – 125‐BN, Lab
Vision Corporation). The tissues were washed for 3 × 5
min with PBS after secondary antibody administration.
Then, after incubating with streptavidin peroxidase (TS
‐ 125‐HR, Lab Vision Corporation) for 30 min at room
temperature in humid environment, it was taken into
PBS. The 3‐amino‐9‐ethylcarbazole (AEC) Substrate +
AEC Chromogen (AEC Substrate, TA‐015 and HAS, AEC
Chromogen, TA‐002‐HAC, Lab Vision Corporation)
solution was dropped onto the tissues. Following this
procedure, after the image signal was received under a light
microscope, the tissues were washed simultaneously with
PBS. Tissues that were contrasted with Mayer’s hematoxylin
were passed through PBS and distilled water and closed
with the appropriate closure solution (Large Volume
Vision Mount, TA‐125‐UG, Lab Vision Corporation). The
preparations were examined, and photographed with a
computer‐assisted Leica DM500 light microscope (Leica
Microsystems GmbH, Wetzlar, Germany).
Histoscore was calculated for immunohistochemical
staining. Histoscore = distribution (0.1 = under 25%;
0.4 = 26%–50%; 0.6 = 50%–75%; 0.9 = 76%–100%) ×
intensity (0 = no staining; + 0.5 = very little staining; + 1
= little staining; + 2 = medium staining; + 3 = very strong
staining) [21].
2.7. Statistical analysis
When a power analysis of 80% power and 0.05 significance
level was performed for the variable with the widest
standard deviation from the variables to be used in the
study, it was calculated that there should be at least 5
optimally 7 subjects in each group. SPSS 21.0 software
(IBM Corp., Armonk, NY, USA) was used for the
statistical analysis of data. The Kolmogorov–Smirnov
and Shapiro–Wilk tests were used as tests of normality
for the continuous variables. Nonnormally distributed
data was expressed as the median (minimum‐maximum).
Binary comparisons were done with Mann–Whitney U
test. Categorical variables were compared with chi-square
test and Fisher’s exact test variables? where applicable. A
P value smaller than 0.05 was considered as statistically
significant.
3. Results
3.1. Ovarian weights
The ratio of ovarian tissue to body weight was significantly
increased in OHSS group compared to the control group
(P < 0.001), (Figure 1), (Table 1).
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3.2. Congestion and edema
There was a significant increase in congestion (P = 0.002)
and edema (P = 0.001) in the OHSS group (Figure 2),
(Table 2).
3.3. Apoptosis
The apoptosis score was significantly increased in OHSS
group compared to the control group (P = 0.001), (Figure
2), (Table 2).
3.4. TRPM2 immunoreactivity
TRPM2 immunoreactivity was significantly increased in
OHSS group compared to the control group (P = 0.001),
(Figure 3), (Table 2).
3.5. Biochemical findings
The levels of TNF‐α, VEGF and MDA were significantly
increased in OHSS group compared to the control group
(P = 0.007, P = 0.017 and P = 0.004, respectively) (Table 3).
4. Discussion
In our study, we found a significant increase in TRPM2
immunoreactivity in OHSS group. Increased tissue MDA
levels may be the result of impaired tissue oxygenation
due to increased congestion or edema in hyperstimulated
ovaries. In our study, TRPM2 immunoreactivity has been
investigated for the first time in the pathophysiology of
OHSS. Therefore, we think that our study may be a role
model for future studies by pointing out this gap in the
literature.
It has been shown that severe OHSS is associated
with massively enlarged ovaries [22]. VEGF is a powerful
vascular permeability mediator. It also plays a role in
vascularization of the corpus luteum [23,24]. Pala et al.
[25] have suggested that the relative hypoxia in enlarged
ovaries in the rat model with OHSS may also contribute
to the increase in VEGF. In our study, due to increased
ovarian weight of OHSS group, we considered ovaries
with OHSS as tumor tissues as every ovarian follicle has a
rich microvascular network [26]. Even though the corpus
luteum is a temporary tissue, endothelial cells form one of
the highest vascularized tissues in the body, representing
more than 50% of all cells [27]. In our study, we detected
significantly increased angiogenesis and ovarian weight in
OHSS group.
Endothelial TRP channels have been shown to be
associated with angiogenesis and vascular remodeling
because they can activate endothelial cell proliferation,
migration, adhesion, tubulogenesis, and intracellular
signaling pathways associated with permeability [28].
Endothelial TRP channels can control angiogenesis by
mediating Ca2+ input in response to extracellular growth
factors such as VEGF and bFGF that are free in peripheral
circulation with ischemic damage or growing tumors [29].
Alternatively, TRP channels perceive cellular stress factors
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Figure 1. In the ovary with OHSS, increased ovarian size is observed compared to the ovary in the control group.

Table 1. The ratio of ovarian tissue to body weight.
Groups

Ovary / body weight (×10–3)

G1

0.45 (0.28–0.59)

G2

1.15 (0.89–1.66)a

P value

0.001

Note: values are presented as median (min-max).
G1 = Sham group; G2 = OHSS group.
a
Compared to control group (P < 0.05).

such as an increase in ROS production or a decrease in
Mg2+ levels, which ultimately stimulates arteriogenesis
[30]. An increased volume of ovaries with OHSS will
require an increase in angiogenesis as well as VEGF
expression, as in tumor tissue. Increased TRPM2 activity
in our OHSS group may also induce angiogenesis along
with increased VEGF.
Reactive oxygen species (ROS) produced by
inflammation and injured tissues cause disruption in the
vascular barrier, causing edema formation as a result of
increased endothelial permeability [31]. TRPM2 has been
shown to mediate endothelial hyperpermeability induced
by H2O2 in human pulmonary artery endothelial cells
[32]. Suppression of TRPM2 expression has been shown
to reduce renal fibrosis induced by unilateral urethral
obstruction, and suppress inflammatory cell infiltration
and release of pro‐inflammatory factors [33]. It is also
found that TRPM2 suppression significantly reduces
TNF‐α and IL‐1β expression induced by TGF‐21 in HK2
cells [33]. The increase in MDA levels, a marker of ROS
level [34], together with VEGF and TNF‐α levels in our

OHSS group may be due to ovarian hypoxia. TNF‐α is
cytotoxic for the endothelial cells produced by corpus
luteum [35]. According to our experiment, increased
MDA levels in our OHSS group indicate an increase
in ROS production and a hypoxic environment due to
increased congestion and edema. Increased TNF-α level
also suggests that OHSS causes an inflammatory response
in the ovary tissue. We also found an increase in TRPM2
immunoreactivity scores with increased MDA and TNF-α
levels and VEGF in our OHSS group. This may indicate
to us that there may be a relationship between increased
angiogenesis and vascular permeability and TRPM2
immunoreactivity in OHSS’ pathophysiology. We detected
significant congestion and edema in our OHSS group. This
shows the increase in permeability in the ovary formed
OHSS. According to the results of our histopathological
and biochemical parameters in our experiment, it is clear
that we do not have enough evidence to say that TRPM2
plays a direct role in the pathophysiology of OHSS.
Apoptosis of luteal endothelial cells in response to
TNF‐α and shrunken nuclei, DNA fragmentation and
caspase-3 activation are all associated with morphological
and biochemical properties of apoptosis [35]. The high
levels of TNF‐α in OHSS group showed that OHSS can
cause endothelial damage in ovarian follicles. Increased
TNF‐α levels may explain the significant increase in
apoptosis score in OHSS group.
In our study, increased apoptosis in correlation with
the increase in TRPM2 may suggest that OHSS may cause
a TRPM2‐mediated injury in the ovarian tissue. TRPM2
activation has been shown to play a role in stimulating the
apoptotic pathway [36]. Eraslan et al. [37] have suggested
that TRPM2 inhibition is effective in preventing ischemic
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Figure 2. Hematoksilen & Eozin staining: significant ovarian size increase is observed in the OHSS group ( 4 magnification, scale bar =
500 µm) black arrow = follicles of various types; red arrow = congestion; black star = edema.
TUNEL staining: TUNEL positive cells are observed in the granulosa cells of the follicles and in the stromal cells (black arrow).
Table 2. Congestion, edema, TRPM2 immunoreactivity histoscore and apoptotic index (values are median (min-max).
Groups

Congestion

Edema

TRPM2

G1

1.00 (0.00–1.00)

0.00 (0.00–1.00)

0.20 (0.10–0.30)

3.14 (2.00–5.00)

G2

2.00 (1.00–3.00)

2.00 (1.00–3.00)

0.80 (0.60–0.90)

10.28 (8.00–13.00)a

P values

0.002

0.001

0.001

0.001

a

a

Apoptotic index (%)
a

Note: values are presented as median (min-max).
G1 = Sham group; G2 = OHSS group; TRPM2 = transient receptor potential melastatin 2.
a
Compared to control group (P < 0.05).

acute kidney injury by alleviating oxidative stress,
inflammation and apoptosis. However, even though some
studies support the paradigm which suggest that TRPM2
activation causes cell death through a continuous increase
in intracellular calcium levels [9,38] or increased cytokine
production that increases tissue damage [39]; a number of
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physiological model systems have suggested that calcium
intake through TRPM2 channels is a protective step rather
than being harmful. TRPM2 inhibition has increased cell
damage in pyramidal neurons exposed to oxidative injury
[40]. Based on the results, TRPM2 channels sensitive to
oxidative stress can facilitate the formation of oxidative
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Figure 3. TRPM2 immune positive cells are observed in the ovarian stroma (black arrow).

Table 3. TNF-α, VEGF and MDA levels of all groups.
Groups

TNF-α (ng/g protein)

VEGF (ng/mg protein)

MDA (nmol/mg protein)

G1

39.50 (23.37–56.26)

1.12 (0.85–1.42)

2.59 (1.73–4.35)

G2

61.84a (41.24–79.41)

1.75a (1.11–4.06)

4.67a (3.42–6.85)

P values

0.007

0.017

0.004

Note: values are presented as median (min‐max).
G1 = Sham group; G2 = OHSS group; VEGF = vascular endothelial growth factor; TNF-α = tumor necrosis factor-alpha; MDA =
malondialdehyde.
a
Compared to control group, (P < 0.05).

damage and apoptosis, as well as induce angiogenesis and
have a protective effect on ovarian tissue from oxidative
damage in OHSS. As TRPM2 activity increases the severity
of OHSS, it may also be involved in limiting the severity
of OHSS by taking part in ovarian homeostasis. This issue
can be clarified by further physiological and biochemical
experimental studies in which mild, moderate, and severe
OHSS groups are included.
Our study has some limitations: in order to prevent
violation of animal rights, the study was performed in a
small group of rats. As this was an experimental study,
the results obtained from this study cannot mimic the
results in humans. On the other hand, our study has some
strong aspects. This was the first study that investigated the
TRPM2 activity in OHSS and its pathophysiology from a
different perspective and its results can pave the way for
new studies.

In conclusion, we showed an increase in TRPM2
activity along with increased tissue MDA levels, vascular
congestion, apoptosis scores in OHSS-developed ovaries.
The increase in TRPM2 channel activity gives a different
point of view on OHSS physiopathology.
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